We use cookies on this site to enable your digital experience. By continuing to use this site, you are agreeing to our cookie policy. close

FTC Moves To Squash $3.1B CLS-Talecris Merger

Law360 (May 28, 2009, 12:00 AM EDT) -- The Federal Trade Commission has officially moved to block blood plasma-derived therapeutics company CSL Ltd.'s proposed $3.1 billion acquisition of rival Talecris Biotherapeutics, a deal the agency claims will reduce competition...
To view the full article, register now.
Law360 Pro Say Podcast
Check out Law360's new podcast, Pro Say, which offers a weekly recap of both the biggest stories and hidden gems from the world of law.